SCHEMBL20176636

SCHEMBL20176636

c1ccc(-c2c3ccccc3c(-c3ccc(-c4ccc5oc6cc7ccccc7cc6c5c4)cn3)c3ccccc23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.40
ESR2 Q92731 6/20 0.40
PLA2G2A P14555 3/20 0.36
PLA2G4A P47712 3/20 0.36
PIK3CD O00329 1/20 0.36
PIK3CA P42336 1/20 0.36
PIK3CB P42338 1/20 0.36
MTOR P42345 1/20 0.36
PIK3CG P48736 1/20 0.36
CDK1 P06493 2/20 0.35
CCNB1 P14635 2/20 0.35
CCNE1 P24864 2/20 0.35
CDK2 P24941 2/20 0.35
GRM4 Q14833 1/20 0.35
CCNE2 O96020 1/20 0.35
GSK3B P49841 1/20 0.35
CDK5 Q00535 1/20 0.35
CDK5R1 Q15078 1/20 0.35
MAPK1 P28482 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20176705 0.99 ESR1 (0.40) ESR1ESR2PLA2G2APLA2G4APIK3CD
SCHEMBL26161172 0.99 ESR1 (0.40) ESR1ESR2PLA2G2APLA2G4APIK3CD
SCHEMBL26160909 0.99 ESR1 (0.40) ESR1ESR2PLA2G2APLA2G4APIK3CD
SCHEMBL26161377 0.96 ESR1 (0.38) ESR1ESR2PLA2G2APLA2G4APIK3CD
SCHEMBL26160910 0.96 ESR1 (0.40) ESR1ESR2PLA2G2APLA2G4APIK3CD
SCHEMBL26161379 0.95 ESR1 (0.37) ESR1ESR2PLA2G2APLA2G4APIK3CD
SCHEMBL20176793 0.93 ESR1 (0.39) ESR1ESR2PLA2G2APLA2G4APIK3CD
SCHEMBL26161097 0.93 ESR1 (0.39) ESR1ESR2PLA2G2APLA2G4APIK3CD
SCHEMBL20176803 0.93 CYP11B1 (0.37) ESR1ESR2GRM4MAPTNPC1
SCHEMBL20176698 0.93 ESR1 (0.40) ESR1ESR2PLA2G2APLA2G4APIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
WO-2018093231-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME 주식회사 두산 2018-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same OR10J3, ICMT, SLCO4C1 ESR1 310/4885ESR2 934/4885PLA2G2A 3903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.